フルアルプラゾラム

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

  H312：皮膚に接触すると有害

  H332：吸入すると有害

• 注意書き

  P261：粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。

  P264：取扱い後は皮膚をよく洗うこと。

  P264：取扱い後は手や顔をよく洗うこと。

  P270：この製品を使用する時に、飲食または喫煙をしないこ と。

  P271：屋外または換気の良い場所でのみ使用すること。

  P280：保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。

  P301+P312：飲み込んだ場合：気分が悪い時は医師に連絡する こと。

  P302+P352：皮膚に付着した場合：多量の水と石鹸で洗うこと。

  P304+P340：吸入した場合：空気の新鮮な場所に移し、呼吸しやすい 姿勢で休息させること。

  P312：気分が悪い時は医師に連絡すること。

  P322：特別な処置が必要である（このラベルの．．． を見よ）。

  P330：口をすすぐこと。

  P363：汚染された衣類を再使用す場合には洗濯をすること。

  P501：内容物/容器を．．．に廃棄すること。

フルアルプラゾラム 化学特性,用途語,生産方法

• 説明

  Flualprazolam (Item No. 24481) is an analytical reference material categorized as a benzodiazepine. This product is intended for research and forensic applications.
  Flualprazolam is structurally related to the triazolo-benzodiazepine, alprazolam. As a class of drugs, benzodiazepines produce central nervous system (CNS) depression and are commonly used to treat, panic disorders, anxiety, and insomnia. The United States Food and Drug Administration has not approved flualprazolam for therapeutic use.

• 使用

  Illicit Uses: Flualprazolam is generally abused for its sedative/hypnotic effects. Reports from online drug user forums describe it to be similar to clonazepam and alprazolam.
  User Population: Flualprazolam is used as a recreational substance in the United States. It is generally abused by young adults, especially males.

• 定義

  Flualprazolam is a 1,2,4-triazolobenzodiazepine. It is structurally similar to alprazolam (of which it is the 2-fluoro derivative),triazolam (replaces the chlorine of triazolam with fluorine at the 2-position on the phenyl ring),and flubromazolam(replaces bromine with chlorine at the 8-positionon the benzodiazepine moiety). It was first developed and patented in 1976.

• 生物学的応用

  Flualprazolam, a 2′-fluoro derivative of alprazolam, is a benzodiazepine sold as designer drug on the illicit drug market.
  Flualprazolam is a tranquilizer of the triazolobenzodiazepine (TBZD) class, which are benzodiazepines (BZDs) fused with a triazole ring. It was first synthesised in 1976, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified as such in Sweden in 2018. It can be described as the 2'-fluoro derivative of alprazolam, or the fluoro instead of chloro analogue of triazolam, and has similar sedative and anxiolytic effects.

• 貯蔵

  -20°C

• 輸送方法

  Room Temperature in continental US; may vary elsewhere.

• Mode of action

  Flualprazolam is an agonist at thebenzodiazepine siteof the gamma-aminobutyric acid (GABAA) receptor. Its pharmacological effects are similar to those of other benzodiazepines, such as alprazolam，which is currently controlled under the Convention on Psychotropic Substances of 1971.
  User reports have indicated that flualprazolam depresses central nervous system function, with effects such as sedation, loss of memory and disinhibition,similar to other benzodiazepines.

• 規制状況(Regulatory Status)

  Flualprazolam is banned in Sweden, also is illegal in the UK. In December 2019, the World Health Organization recommended flualprazolam for international scheduling as a Schedule IV medication under the Convention on Psychotropic Substances.

フルアルプラゾラム 上流と下流の製品情報

28910-91-0, フルアルプラゾラム キーワード